🎉 Finosauras is now  SarasRead more
Remus Pharmaceuticals Ltd logo

Remus Pharmaceuticals Ltd - Share Price Target 2026

(NSE: REMUS)

Sector: Healthcare

Market Cap: 950.97 Cr

896.70

-

772.70

Target Price Range

733.95

-21.70 (-2.96%)

CMP

Bearish

As on 16 Dec 2025, 03:30 pm

Market Trends

Based on 6 technical indicators.
Bullish1
Bearish3
Neutral2
Agg. Profit Potential20.49%
Agg. Risk 13.30%

Last updated on: 16/12/2025, 3:30 pm

Returns

PeriodReturn %
1 Month-13.56
3 Months-62.77
1 Year-71.40
5 Years--

Last updated on: 06/09/2025, 9:30 AM

Institutional Holdings

InstitutePercentageNo. of Shares
India Emerging Giants Fund Limited4.76%560,500

Last updated on: 9/30/2025, 12:00:00 AM

Loading technical analysis...

Fundamental Data

Fundamental Analysis

P/E Ratio

47.79

P/B Ratio

3.83

PEG Ratio

1.70

ROE

10.06%

EPS

16.89

Dividend Yield

0.09%

Market Cap

950.97 Cr

Sector

N/A

Last Updated: 12 Nov 2025, 01:30 pm

Peer Comparison

CompanySentimentTarget PriceUpside

About : Remus Pharmaceuticals Ltd.

Incorporated Year

2015

City and State

Ahmedabad, Gujarat

Listing Date

Director's Name

Sanjana Sanjeev Shah

Revenue

79.16 Cr

Net Profit

26.64 Cr